Restoration of full-length dystrophin expression through exon skipping in Duchenne muscular dystrophy patients with single exon duplications

被引：0
作者：
Nicolau, S. [1 ]
Malhotra, J. [2 ]
Iammarino, M. [1 ]
Reash, N. [1 ]
Lowes, L. [1 ]
Flanigan, K. [1 ,3 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Sarepta Therapeut, Cambridge, MA USA
[3] Ohio State Univ, Columbus, OH USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LSVP.32
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Exon-skipping therapy for Duchenne muscular dystrophy
    Nakamura, Akinori
    Takeda, Shin'ichi
    NEUROPATHOLOGY, 2009, 29 (04) : 494 - 501
  • [22] Clinical trials of exon skipping in Duchenne muscular dystrophy
    Mendell, Jerry R.
    Sahenk, Zarife
    Rodino-Klapac, Louise R.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09): : 683 - 690
  • [23] Exon-skipping advances for Duchenne muscular dystrophy
    Echevarria, Lucia
    Aupy, Philippine
    Goyenvalle, Aurelie
    HUMAN MOLECULAR GENETICS, 2018, 27 (R2) : R163 - R172
  • [24] Dystrophin restoration by exon 53 skipping in patients with Duchenne muscular dystrophy after viltolarsen treatment: phase 2 study update
    Clemens, P.
    Rao, V.
    Connolly, A.
    Zaidman, C.
    Harper, A.
    Mah, J.
    Morgenroth, L.
    Yamashita, T.
    Hoffman, E.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S165 - S166
  • [25] Dystrophin Restoration by Exon 53 Skipping in Patients with Duchenne Muscular Dystrophy after Viltolarsen Treatment: Phase 2 Study Update
    Rao, V
    Connolly, A.
    Zaidman, C.
    Harper, A.
    Mah, J.
    Smith, E.
    McDonald, C.
    Morgenroth, L.
    Yamashita, T.
    Hoffman, E.
    Clemens, P.
    ANNALS OF NEUROLOGY, 2019, 86 : S128 - S128
  • [26] The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
    Partridge, Terence
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (09) : 1165 - 1170
  • [27] Antisense-induced exon skipping in Duchenne muscular dystrophy patients
    Janson, A. A. M.
    Ginjaar, I. H. B.
    Aartsma-Rus, A.
    van Ommen, G. -J. B.
    van der Kooi, A.
    de Kimpe, S.
    Ekhart, P.
    Platenburg, G.
    Verschumen, J. J. G. M.
    van Deutekom, J. C. T.
    NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 722 - 722
  • [28] Optimization of Antisense Oligonucleotide Drugs for Skipping Dystrophin Exon 51 and 53 in Duchenne Muscular Dystrophy
    Wu, Bo
    MOLECULAR THERAPY, 2018, 26 (05) : 148 - 148
  • [29] Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice
    Zhou, Yuan
    Zhang, Chen
    Xiao, Weidong
    Herzog, Roland W.
    Han, Renzhi
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [30] Less is more: therapeutic exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    van Ommen, Gert-Jan B.
    LANCET NEUROLOGY, 2009, 8 (10) : 873 - 875
12345